UE Lifesciences raises $80,000

What does UE LifeSciences do?

 UE LifeSciences, is a US based maker of a low cost, portable breat cancer screening device. 90% of the developing worls and millions of women do not have access to breast cancer early detection.  Breast cancer incidence is expected to continue growing and increasing mortality rate, all because of late stage detection. UE Life Sciences with its innovative technologies and a passionate team  aims in making the hope of early detection, a reality. It has been selected for the StartHealth Program which focuses on early stage health tech startups.

How much UE LifeSciences was funded?

Unitus Seed fund has selected its second startup, UE Life Sciences under its StartHealth Investment Program, where the startup will receive an initial funding on $80,000 and a potential follow up investment of at least $160,000.

What is next for UE Lifesciences?

This US and India based startup has invented a portable breast screening device which helps in detecting breast cancer in its early stage. The startup has plans to use the investments to make breast screening to massed by reducing the cost of diagnosis.

It will use the funding for fabrication of our core component to India, make it at scale and reduce the cost of production. The StartHealth Program will allow the company to work with Narayan Health and Manipal Hospitals towards a broader clinical validation.

More about UE Lifesciences

UE Lifesciences was launched in January 2009. It has developed some breakthrough technology which has the potential for dramatically improving the quality breast cancer screening accessibility.

It is a Philadelphia based company which will sell the product on a pay per use model instead of direct sales, which will help the doctors in immediately start offering private, safe and pain free breast examinations. Apart from India, this company is targeting other emerging markets in Latin America, Middle East and South East Asia.